Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IL1F9 |
| Upstream (Parents) |
|---|
| (<<) ANKRD57 → IL1F9 |
| (<<) CEND1 → IL1F9 |
| (<<) GLS → IL1F9 |
| (<<) MAL → IL1F9 |
| (<<) MAP3K9 → IL1F9 |
| (<<) N4BP3 → IL1F9 |
| (<<) NFIL3 → IL1F9 |
| (<<) POU3F3 → IL1F9 |
| (<<) PRKACA → IL1F9 |
| (<<) PTMS → IL1F9 |
| (<<) RPS14 → IL1F9 |
| (<<) RPS6KA3 → IL1F9 |
| (<<) SPINK5 → IL1F9 |
| (<<) TPP1 → IL1F9 |
| Downstream (Children) |
|---|
| IL1F9 → ALPPL2 (>>) |
| IL1F9 → CEBPE (>>) |
| IL1F9 → CRCT1 (>>) |
| IL1F9 → ERBB3 (>>) |
| IL1F9 → HCN2 (>>) |
| IL1F9 → NRAS (>>) |
| IL1F9 → SPRR2C (>>) |
| IL1F9 → ZNF750 (>>) |
